APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-inflammatory and Antipyretic Granules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-inflammatory and Antipyretic Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173965070327 December 2025196 pages

Choose your research edition.

Industry ResearchAnti-inflammatory and Antipyretic Granules Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-inflammatory and Antipyretic Granules Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Anti-inflammatory and Antipyretic Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-inflammatory and Antipyretic Granules Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-inflammatory and Antipyretic Granules Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Anti-inflammatory and Antipyretic Granules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-inflammatory and Antipyretic Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-inflammatory and Antipyretic Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-inflammatory and Antipyretic Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-inflammatory and Antipyretic Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-inflammatory and Antipyretic Granules include Dong'e Ejiao Co., Ltd., Guangdong Baihe Pharmaceutical Co., Ltd., Guangxi Tiantianle Pharmaceutical Co., Ltd., Hebei Tiancheng Pharmaceutical Co., Ltd., Hubei Dongxin Pharmaceutical Co., Ltd., Hubei Nordeson Pharmaceutical Co., Ltd., Jilin Xianfeng Technology Pharmaceutical Co., Ltd., Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. and Liaoning Xingao Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-inflammatory and Antipyretic Granules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-inflammatory and Antipyretic Granules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-inflammatory and Antipyretic Granules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-inflammatory and Antipyretic Granules market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-inflammatory and Antipyretic Granules Segment by Company

Dong'e Ejiao Co., Ltd.

Guangdong Baihe Pharmaceutical Co., Ltd.

Guangxi Tiantianle Pharmaceutical Co., Ltd.

Hebei Tiancheng Pharmaceutical Co., Ltd.

Hubei Dongxin Pharmaceutical Co., Ltd.

Hubei Nordeson Pharmaceutical Co., Ltd.

Jilin Xianfeng Technology Pharmaceutical Co., Ltd.

Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.

Liaoning Xingao Pharmaceutical Co., Ltd.

Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.

Shaanxi Buchang Pharmaceutical Co., Ltd.

Shaanxi Han Tang Pharmaceutical Co., Ltd.

Shenyang Junyuan Pharmaceutical Co., Ltd.

Sichuan Kelun Pharmaceutical Co., Ltd.

Sichuan Luye Pharmaceutical Co., Ltd.

Yunnan Baiyao Group Co., Ltd.

Yunnan Longfa Pharmaceutical Co., Ltd.

Anti-inflammatory and Antipyretic Granules Segment by Type

Pack of 10

Pack of 16

Anti-inflammatory and Antipyretic Granules Segment by Application

Online Sales

Offline Sales

Anti-inflammatory and Antipyretic Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory and Antipyretic Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory and Antipyretic Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory and Antipyretic Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-inflammatory and Antipyretic Granules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-inflammatory and Antipyretic Granules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-inflammatory and Antipyretic Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-inflammatory and Antipyretic Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-inflammatory and Antipyretic Granules Industry Trends Table 2. Anti-inflammatory and Antipyretic Granules Industry Drivers Table 3. Anti-inflammatory and Antipyretic Granules Industry Opportunities and Challenges Table 4. Anti-inflammatory and Antipyretic Granules Industry Restraints Table 5. Global Anti-inflammatory and Antipyretic Granules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-inflammatory and Antipyretic Granules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Manufacturers Table 9. Global Anti-inflammatory and Antipyretic Granules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Anti-inflammatory and Antipyretic Granules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-inflammatory and Antipyretic Granules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-inflammatory and Antipyretic Granules Manufacturers, Product Type & Application Table 13. Global Anti-inflammatory and Antipyretic Granules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-inflammatory and Antipyretic Granules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pack of 10 Table 17. Major Manufacturers of Pack of 16 Table 18. Global Anti-inflammatory and Antipyretic Granules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 20. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (K Units) Table 21. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021-2026) Table 22. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2027-2032) Table 23. Global Anti-inflammatory and Antipyretic Granules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2026) & (K Units) Table 25. Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2027-2032) & (K Units) Table 26. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021-2026) Table 27. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Online Sales Table 29. Major Manufacturers of Offline Sales Table 30. Global Anti-inflammatory and Antipyretic Granules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 32. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (K Units) Table 33. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021-2026) Table 34. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2027-2032) Table 35. Global Anti-inflammatory and Antipyretic Granules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2026) & (K Units) Table 37. Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2027-2032) & (K Units) Table 38. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021-2026) Table 39. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2027-2032) Table 40. Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Anti-inflammatory and Antipyretic Granules Sales by Region (2021-2026) & (K Units) Table 42. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2021-2026) Table 43. Global Anti-inflammatory and Antipyretic Granules Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Anti-inflammatory and Antipyretic Granules Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Anti-inflammatory and Antipyretic Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 47. North America Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 48. Europe Anti-inflammatory and Antipyretic Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 50. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 57. Global Anti-inflammatory and Antipyretic Granules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2021-2026) Table 61. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2027-2032) Table 62. Dong'e Ejiao Co., Ltd. Company Information Table 63. Dong'e Ejiao Co., Ltd. Business Overview Table 64. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 66. Dong'e Ejiao Co., Ltd. Recent Development Table 67. Guangdong Baihe Pharmaceutical Co., Ltd. Company Information Table 68. Guangdong Baihe Pharmaceutical Co., Ltd. Business Overview Table 69. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 71. Guangdong Baihe Pharmaceutical Co., Ltd. Recent Development Table 72. Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information Table 73. Guangxi Tiantianle Pharmaceutical Co., Ltd. Business Overview Table 74. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 76. Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Development Table 77. Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information Table 78. Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview Table 79. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 81. Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Development Table 82. Hubei Dongxin Pharmaceutical Co., Ltd. Company Information Table 83. Hubei Dongxin Pharmaceutical Co., Ltd. Business Overview Table 84. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 86. Hubei Dongxin Pharmaceutical Co., Ltd. Recent Development Table 87. Hubei Nordeson Pharmaceutical Co., Ltd. Company Information Table 88. Hubei Nordeson Pharmaceutical Co., Ltd. Business Overview Table 89. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 91. Hubei Nordeson Pharmaceutical Co., Ltd. Recent Development Table 92. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information Table 93. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Business Overview Table 94. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 96. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Development Table 97. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information Table 98. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview Table 99. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 101. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Development Table 102. Liaoning Xingao Pharmaceutical Co., Ltd. Company Information Table 103. Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview Table 104. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 106. Liaoning Xingao Pharmaceutical Co., Ltd. Recent Development Table 107. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information Table 108. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Business Overview Table 109. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 111. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Development Table 112. Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information Table 113. Shaanxi Buchang Pharmaceutical Co., Ltd. Business Overview Table 114. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 116. Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Development Table 117. Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information Table 118. Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview Table 119. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 121. Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Development Table 122. Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information Table 123. Shenyang Junyuan Pharmaceutical Co., Ltd. Business Overview Table 124. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 126. Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Development Table 127. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information Table 128. Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview Table 129. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 131. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Development Table 132. Sichuan Luye Pharmaceutical Co., Ltd. Company Information Table 133. Sichuan Luye Pharmaceutical Co., Ltd. Business Overview Table 134. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 136. Sichuan Luye Pharmaceutical Co., Ltd. Recent Development Table 137. Yunnan Baiyao Group Co., Ltd. Company Information Table 138. Yunnan Baiyao Group Co., Ltd. Business Overview Table 139. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 141. Yunnan Baiyao Group Co., Ltd. Recent Development Table 142. Yunnan Longfa Pharmaceutical Co., Ltd. Company Information Table 143. Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview Table 144. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 146. Yunnan Longfa Pharmaceutical Co., Ltd. Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Anti-inflammatory and Antipyretic Granules Distributors List Table 150. Anti-inflammatory and Antipyretic Granules Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Anti-inflammatory and Antipyretic Granules Product Image Figure 2. Global Anti-inflammatory and Antipyretic Granules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-inflammatory and Antipyretic Granules Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-inflammatory and Antipyretic Granules Sales (2021-2032) & (K Units) Figure 5. Global Anti-inflammatory and Antipyretic Granules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-inflammatory and Antipyretic Granules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pack of 10 Image Figure 9. Pack of 16 Image Figure 10. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Anti-inflammatory and Antipyretic Granules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021-2032) Figure 13. Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021-2032) Figure 16. Online Sales Image Figure 17. Offline Sales Image Figure 18. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Anti-inflammatory and Antipyretic Granules Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021-2032) Figure 21. Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021-2032) Figure 24. North America Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2032) Figure 26. U.S. Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2032) Figure 31. Germany Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2032) Figure 38. China Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Market Share by Country (2021-2032) Figure 46. Brazil Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Anti-inflammatory and Antipyretic Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Anti-inflammatory and Antipyretic Granules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Figure 57. North America Anti-inflammatory and Antipyretic Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Figure 59. Europe Anti-inflammatory and Antipyretic Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Anti-inflammatory and Antipyretic Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Anti-inflammatory and Antipyretic Granules Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Anti-inflammatory and Antipyretic Granules Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pack of 10
  • Pack of 16
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Dong'e Ejiao Co., Ltd.
  • Guangdong Baihe Pharmaceutical Co., Ltd.
  • Guangxi Tiantianle Pharmaceutical Co., Ltd.
  • Hebei Tiancheng Pharmaceutical Co., Ltd.
  • Hubei Dongxin Pharmaceutical Co., Ltd.
  • Hubei Nordeson Pharmaceutical Co., Ltd.
  • Jilin Xianfeng Technology Pharmaceutical Co., Ltd.
  • Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  • Liaoning Xingao Pharmaceutical Co., Ltd.
  • Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.
  • Shaanxi Buchang Pharmaceutical Co., Ltd.
  • Shaanxi Han Tang Pharmaceutical Co., Ltd.
  • Shenyang Junyuan Pharmaceutical Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Sichuan Luye Pharmaceutical Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Yunnan Longfa Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-inflammatory and Antipyretic Granules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-inflammatory and Antipyretic Granules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-inflammatory and Antipyretic Granules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-inflammatory and Antipyretic Granules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-inflammatory and Antipyretic Granules Market Dynamics
  1. 2.1 Anti-inflammatory and Antipyretic Granules Industry Trends
  2. 2.2 Anti-inflammatory and Antipyretic Granules Industry Drivers
  3. 2.3 Anti-inflammatory and Antipyretic Granules Industry Opportunities and Challenges
  4. 2.4 Anti-inflammatory and Antipyretic Granules Industry Restraints
3 Anti-inflammatory and Antipyretic Granules Market by Manufacturers
  1. 3.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-inflammatory and Antipyretic Granules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-inflammatory and Antipyretic Granules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-inflammatory and Antipyretic Granules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-inflammatory and Antipyretic Granules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-inflammatory and Antipyretic Granules Manufacturers, Product Type & Application
  7. 3.7 Global Anti-inflammatory and Antipyretic Granules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-inflammatory and Antipyretic Granules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-inflammatory and Antipyretic Granules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-inflammatory and Antipyretic Granules Tier 1, Tier 2, and Tier 3
4 Anti-inflammatory and Antipyretic Granules Market by Type
  1. 4.1 Anti-inflammatory and Antipyretic Granules Type Introduction
  2. 4.1.1 Pack of 10
  3. 4.1.2 Pack of 16
  4. 4.2 Global Anti-inflammatory and Antipyretic Granules Sales by Type
  5. 4.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032)
  7. 4.2.3 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Anti-inflammatory and Antipyretic Granules Revenue by Type
  9. 4.3.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2032)
  11. 4.3.3 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021-2032)
5 Anti-inflammatory and Antipyretic Granules Market by Application
  1. 5.1 Anti-inflammatory and Antipyretic Granules Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Anti-inflammatory and Antipyretic Granules Sales by Application
  5. 5.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032)
  7. 5.2.3 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021-2032)
  8. 5.3 Global Anti-inflammatory and Antipyretic Granules Revenue by Application
  9. 5.3.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2032)
  11. 5.3.3 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021-2032)
6 Global Anti-inflammatory and Antipyretic Granules Sales by Region
  1. 6.1 Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-inflammatory and Antipyretic Granules Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-inflammatory and Antipyretic Granules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-inflammatory and Antipyretic Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-inflammatory and Antipyretic Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-inflammatory and Antipyretic Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-inflammatory and Antipyretic Granules Revenue by Region
  1. 7.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Region
  2. 7.1.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-inflammatory and Antipyretic Granules Revenue (2021-2032)
  8. 7.2.2 North America Anti-inflammatory and Antipyretic Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-inflammatory and Antipyretic Granules Revenue (2021-2032)
  11. 7.3.2 Europe Anti-inflammatory and Antipyretic Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-inflammatory and Antipyretic Granules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-inflammatory and Antipyretic Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Dong'e Ejiao Co., Ltd.
  2. 8.1.1 Dong'e Ejiao Co., Ltd. Company Information
  3. 8.1.2 Dong'e Ejiao Co., Ltd. Business Overview
  4. 8.1.3 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  6. 8.1.5 Dong'e Ejiao Co., Ltd. Recent Developments
  7. 8.2 Guangdong Baihe Pharmaceutical Co., Ltd.
  8. 8.2.1 Guangdong Baihe Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Guangdong Baihe Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  12. 8.2.5 Guangdong Baihe Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Guangxi Tiantianle Pharmaceutical Co., Ltd.
  14. 8.3.1 Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Guangxi Tiantianle Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  18. 8.3.5 Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Hebei Tiancheng Pharmaceutical Co., Ltd.
  20. 8.4.1 Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  24. 8.4.5 Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Hubei Dongxin Pharmaceutical Co., Ltd.
  26. 8.5.1 Hubei Dongxin Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Hubei Dongxin Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  30. 8.5.5 Hubei Dongxin Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Hubei Nordeson Pharmaceutical Co., Ltd.
  32. 8.6.1 Hubei Nordeson Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Hubei Nordeson Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  36. 8.6.5 Hubei Nordeson Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Jilin Xianfeng Technology Pharmaceutical Co., Ltd.
  38. 8.7.1 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  42. 8.7.5 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  44. 8.8.1 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  48. 8.8.5 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Liaoning Xingao Pharmaceutical Co., Ltd.
  50. 8.9.1 Liaoning Xingao Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  54. 8.9.5 Liaoning Xingao Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.
  56. 8.10.1 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  60. 8.10.5 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Shaanxi Buchang Pharmaceutical Co., Ltd.
  62. 8.11.1 Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Shaanxi Buchang Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  66. 8.11.5 Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Shaanxi Han Tang Pharmaceutical Co., Ltd.
  68. 8.12.1 Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  72. 8.12.5 Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Shenyang Junyuan Pharmaceutical Co., Ltd.
  74. 8.13.1 Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Shenyang Junyuan Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  78. 8.13.5 Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Sichuan Kelun Pharmaceutical Co., Ltd.
  80. 8.14.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  84. 8.14.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Sichuan Luye Pharmaceutical Co., Ltd.
  86. 8.15.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Sichuan Luye Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  90. 8.15.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Yunnan Baiyao Group Co., Ltd.
  92. 8.16.1 Yunnan Baiyao Group Co., Ltd. Company Information
  93. 8.16.2 Yunnan Baiyao Group Co., Ltd. Business Overview
  94. 8.16.3 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  96. 8.16.5 Yunnan Baiyao Group Co., Ltd. Recent Developments
  97. 8.17 Yunnan Longfa Pharmaceutical Co., Ltd.
  98. 8.17.1 Yunnan Longfa Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  102. 8.17.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-inflammatory and Antipyretic Granules Value Chain Analysis
  2. 9.1.1 Anti-inflammatory and Antipyretic Granules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-inflammatory and Antipyretic Granules Production Mode & Process
  6. 9.2 Anti-inflammatory and Antipyretic Granules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-inflammatory and Antipyretic Granules Distributors
  9. 9.2.3 Anti-inflammatory and Antipyretic Granules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst